{"entities":{"Q91853":{"pageid":93143,"ns":120,"title":"Item:Q91853","lastrevid":59432520,"modified":"2026-04-10T12:37:15Z","type":"item","id":"Q91853","labels":{"en":{"language":"en","value":"Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91853$433B9479-F451-4852-BD89-0A9D02A6D2EB","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"3d7c1374d83a26e8f342cb6a4b2a7b0bb03b774e","datavalue":{"value":{"entity-type":"item","numeric-id":57856,"id":"Q57856"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91853$87A4AC87-F9DF-44FC-AB54-9B4A5146E3F0","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"00248d46fa7f5a38c4a83e340a3a0e5a7b2d1b88","datavalue":{"value":"31","type":"string"},"datatype":"string"},"type":"statement","id":"Q91853$69A9EDF3-90C3-47D6-BF7D-8329675FE2EC","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"4e86e8a46af8405237d81676e1bf35d6310827a7","datavalue":{"value":"6","type":"string"},"datatype":"string"},"type":"statement","id":"Q91853$579BE85F-70A7-45F5-A5C4-F8BB9EC6F791","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"7da4c7e194591987c75ddfa03e6c3944552816e1","datavalue":{"value":"572-578","type":"string"},"datatype":"string"},"type":"statement","id":"Q91853$E24D32C9-FE7A-4838-844D-B35B40F901E6","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"a25b7de1c48019e57a7e4af7031d006cb3621d3f","datavalue":{"value":{"time":"+2010-11-00T00:00:00Z","timezone":0,"before":0,"after":0,"precision":10,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q91853$775C7B77-7E07-4D8A-8E2D-0876564A6BB5","rank":"normal"}],"P16":[{"mainsnak":{"snaktype":"value","property":"P16","hash":"c6691b96255ba578577955612d69a7d2fd2ad49f","datavalue":{"value":{"entity-type":"item","numeric-id":91851,"id":"Q91851"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91853$B2E3FC23-B546-4EBB-A0E9-5D39629933C3","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P16","hash":"24ae8c80e82741b9379afb828812f8900589fd04","datavalue":{"value":{"entity-type":"item","numeric-id":91852,"id":"Q91852"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91853$D01C8E3C-7F07-482C-B12A-5CB770D0B147","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q91853$ECC0BF13-E6FE-4402-BA76-8FF8C7FFD4FE","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"84b576fbc2f5c1307eab53fcabc98e3d1f48754f","datavalue":{"value":"Q42141287","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q91853$677730EB-3036-4D85-922E-05090C6E838E","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"859da6d90195f82d8f831d91b44484ab833ca60c","datavalue":{"value":"10.1016/J.CCT.2010.07.008","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q91853$96EEF4F6-24C7-49EC-8DAA-017D3823268A","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/Two-stage_designs_optimal_under_the_alternative_hypothesis_for_phase_II_cancer_clinical_trials"}}}}}